US › Healthcare

Nexgel Inc (NXGL)

US · Healthcare · Medical Instruments & Supplies

$0.42-0.52%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.6M
Revenue YoY
-5.6%
Net profit
$-927,000
Profit YoY
-30.2%
EPS
$-0.11
EPS estimate
$-0.07
Net margin
-35.0%

EPS came in at -0.11 against a street estimate of -0.07 — a miss of 57.1%.

Key statistics

Market cap
$3.8M
Forward P/E
1.4
P/B
0.96
Book value
$0.47
EPS (TTM)
$-0.40
52-week high
$2.89
52-week low
$0.41
50-day MA
$0.52
200-day MA
$1.16
Beta
0.76

Analyst view

Analysts rate Nexgel Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders
14.59%
Institutions
13.18%

Largest institutional holders

FundStake
Geode Capital Management, LLC1.39%
Morgan Stanley - Brokerage Accounts0.60%
Renaissance Technologies Corp0.55%
Vanguard Capital Management, LLC0.53%
Jane Street Group LLC0.46%
Vanguard Fiduciary Trust Co0.37%
FLAX POND CAPITAL, LLC0.22%
XTX Topco Ltd0.19%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Nexgel Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.